Log in to save to my catalogue

Newborn screening in mucopolysaccharidoses

Newborn screening in mucopolysaccharidoses

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d2ae06c5f70e471b87b803d42f62c999

Newborn screening in mucopolysaccharidoses

About this item

Full title

Newborn screening in mucopolysaccharidoses

Publisher

England: BioMed Central

Journal title

Italian journal of pediatrics, 2018-11, Vol.44 (Suppl 2), p.126-126, Article 126

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Newborn screening (NBS) methods and therapeutic options have become increasingly available for mucopolysaccharidoses (MPS), and there is a clear evidence that early intervention significantly improves the outcome. It is recommended that mucopolysaccharidosis type I (MPS I) is included in the US newborn screening panel, and this is currently underwa...

Alternative Titles

Full title

Newborn screening in mucopolysaccharidoses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d2ae06c5f70e471b87b803d42f62c999

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d2ae06c5f70e471b87b803d42f62c999

Other Identifiers

ISSN

1824-7288,1720-8424

E-ISSN

1824-7288

DOI

10.1186/s13052-018-0552-3

How to access this item